about
Application of microRNA in diagnosis and treatment of ovarian cancerMicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatmentA retrospective study on combination therapy with ifosfamide, adriamycin and cisplatin for progressive or recurrent uterine sarcoma.Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).Features of ovarian cancer in Lynch syndrome (Review).Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case.Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)Neural basis of three dimensions of agitated behaviors in patients with Alzheimer diseaseApplication of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects.Uterine transplantation in primates: a mini-review of the literature.Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.A tumor of the uterine cervix with a complex histology in a Peutz-Jeghers syndrome patient with genomic deletion of the STK11 exon 1 region.Case of streptococcal toxic shock syndrome caused by rapidly progressive group A hemolytic streptococcal infection during postoperative chemotherapy for cervical cancer.Indocyanine green fluorescence imaging in the pregnant cynomolgus macaque: childbearing is supported by a unilateral uterine artery and vein alone?[Case report; A case of EBV positive diffuse large B-cell lymphoma of the elderly in stomach reduced by itself in a short period].Excess fluid distribution affects tacrolimus absorption in peritoneal dialysis patients.Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer.Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?Uterus allotransplantation in cynomolgus macaque: a preliminary experience with non-human primate models.Repair of congenital 'disconnected uterus': a new female genital anomaly?The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing TechnologyLaparoscopic Surgery for Ovarian Cyst Infection with Avoidance of Ureteral Injury and Uterine Perforation following Intrauterine Insemination after Abdominal Modified Radical Trachelectomy.Reply of the authorsClinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancerLAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancerSignificance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinomaCurrent state and outlook for drug repositioning anticipated in the field of ovarian cancer
P50
Q26991620-B6EA49A6-9F13-4D76-A16E-659D1506A214Q27011808-43DC0784-F792-4CAC-AD87-A1DD830E51A1Q33415973-D56176EC-65DC-4729-99E5-A5AEF1149396Q33933054-8618C06C-755C-4099-80D2-C8E4A3565DB4Q34265940-6F5C5D2B-2D87-4AB8-AE79-26240943FAC8Q35039169-A7D11847-9635-4768-B58C-37F68397852CQ37269300-A4489DD8-0D5A-452F-9D55-378E7A637271Q37601229-89A66662-746C-45A1-B331-C65B8DAF5DF1Q38186694-FCF68F1C-9C10-4154-A4E8-50F6762D787AQ38210757-8083AEE3-CCB1-4210-9AD1-2848E31F7BB6Q38240724-1A85BB0F-2A61-47D6-A1F2-D06EA9D335A6Q39257685-BF574F5A-3647-4982-B1CB-B7F70296758EQ40238297-B85E0925-2666-456F-912F-189F1DA74799Q43571207-5FC2933C-4435-4BE2-8C99-35F690E8647DQ44065829-31DD0380-7D31-4D0A-9C26-46E908F9C126Q44696405-CC976AD5-D71E-45A2-8968-B8DF9F38DB40Q48107196-16555DDD-C76E-4835-8A8F-4A33BCA0E02CQ48107265-01017951-DB63-4FB1-802B-C288B8453F54Q50459758-A283AC5B-FB80-4CFB-8879-04D6F37EE4A7Q50624890-8FD24EB0-B3CC-49B2-A12C-EDE8E2721E2FQ53042426-4614C27E-912D-4BF9-A7DE-14EBBE67D096Q64119521-D5308824-15DF-4642-BA4E-F9E6D3131A67Q64929192-7D21D389-E3F6-453B-A9A4-EF7618E4E715Q86053553-FAA43649-9058-41D7-B518-01C4A524104BQ88006868-B9DDC148-D34D-4B05-8B32-6264142D41EEQ92487277-D3101D9A-1F7F-42A3-BA50-EFA32E14DFF3Q92487389-569E3D28-0072-4A88-A3A6-98D6AB5658F2Q93385230-8F4675E2-0E8A-46AB-A3C2-D713C753A2F7
P50
description
researcher ORCID ID = 0000-0003-2610-2833
@en
name
Kouji Banno
@ast
Kouji Banno
@en
Kouji Banno
@es
Kouji Banno
@nl
type
label
Kouji Banno
@ast
Kouji Banno
@en
Kouji Banno
@es
Kouji Banno
@nl
prefLabel
Kouji Banno
@ast
Kouji Banno
@en
Kouji Banno
@es
Kouji Banno
@nl
P108
P31
P496
0000-0003-2610-2833